News
NICE recommends Namuscla for NHS to treat genetic disorder
NICE has published draft guidance which recommends a rebranded form of the drug mexiletine (Namuscla), for treating the symptoms of myotonia in adults with non-dystrophic myotonic disorders (NDM).